IOSP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Innospec Inc (IOSP) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the technical indicators show a bullish trend and analysts have a positive outlook, the company's recent financial performance is weak, with significant declines in revenue, net income, and EPS. Additionally, there are no recent news catalysts or significant insider/hedge fund activity to support immediate upside potential. Given the user's impatience and unwillingness to wait for optimal entry points, it is better to hold off on investing until the company demonstrates stronger financial recovery or clear catalysts emerge.
The stock shows bullish moving averages (SMA_5 > SMA_20 > SMA_200), MACD is positive at 0.423, and RSI is neutral at 62.869. The current price of $86.88 is above the pivot level of $85.36, suggesting short-term bullish momentum. Resistance levels are at $89.151 and $91.493, while support levels are at $81.568 and $79.226.
Freedom Capital initiated coverage with a Buy rating and a $93 price target, citing the company as undervalued with potential upside from new products or M&A. Technical indicators suggest a bullish trend.
Weak financial performance in Q3 2025, with revenue down 0.34% YoY, net income down 61.38% YoY, and EPS down 60.90% YoY. No recent news, insider trading, or hedge fund activity to indicate strong sentiment. Congress trading data is also absent.
In Q3 2025, revenue dropped to $441.9M (-0.34% YoY), net income dropped to $12.9M (-61.38% YoY), and EPS dropped to $0.52 (-60.90% YoY). Gross margin also declined to 26.41% (-5.64% YoY).
Freedom Capital initiated a Buy rating with a $93 price target, highlighting the stock as undervalued with potential upside from new products or M&A opportunities. Recent underperformance and bottoming earnings were noted as creating an attractive risk-reward tradeoff.
